[Influenza live attenuated intra-nasal vaccines].
Weil-Olivier
C
C
Neuilly-sur-Seine, France. cweilolivier@gmail.com
D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000097:blood; D000918:Antibody Specificity / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D058872:Epidemics / Q000517:prevention & control; D005602:France; D006801:Humans; D007115:Immunization Schedule; D007117:Immunization, Secondary; D009980:Influenza A virus / Q000276:immunology*; D009981:Influenza B virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D008875:Middle Aged; D015164:Vaccines, Inactivated / Q000008:administration & dosage*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology; D055815:Young Adult
D000914:Antibodies, Viral; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic